RBC Capital analysts shared their outlook on Brown-Forman (NYSE:BF-B) ahead of the company’s Q4/23 earnings announcement, expecting organic growth of (1.5%), compared to the Street estimate of (0.7%), and EPS of $0.40, compared to the Street estimate of ($0.43).
A slight decline in organic sales is because the company lapsed more than 20% organic growth in the back half of 2022, as it was in the early stages of rebuilding global inventories following glass supply chain issues.
For fiscal 2024, the analysts expect an on-algorithm guide with mid-single-digit organic growth and high-single-digit or better organic operating growth. The analysts reiterated their Sector Perform rating and $66 price target on the stock.